X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Video: What is a results-based contract?

By Katie Koziara  |    November 13, 2017
New medicines are revolutionizing how we fight disease, but too often patients have to fight to access innovative treatments. As part of the solution to this problem, biopharmaceutical companies...   Read More

Johnson & Johnson, Pfizer, Walgreens and other CEOs discuss value in the future of health care

By Holly Campbell  |    September 21, 2017
As part of The Value Collaborative, an initiative of America’s biopharmaceutical companies, we recently hosted an event with Bloomberg about unlocking and supporting value in the future of health...   Read More

PhRMA CEO in Forbes - How to negotiate better deals for prescription medicines

By Holly Campbell  |    June 2, 2017
    The following op-ed was authored by PhRMA president and CEO Stephen J. Ubl and published on Forbes here on June 2, 2017. The way our health care system currently pays for prescription...   Read More

ICYMI: Innovative payment models helping provide patient access to new medicines

By Holly Campbell  |    May 5, 2017
As we continue to make remarkable strides to treat our most costly and challenging diseases, there is a renewed focus on ensuring patients have access to the most innovative medicines....   Read More

RA medicines often demonstrate far greater benefits to patients than initially understood

By Lauren Neves  |    April 5, 2017
In the last decade, new therapies to treat rheumatoid arthritis (RA), a progressive and painful autoimmune disorder, have expanded patients’ treatment options and significantly improved outcomes,...   Read More

Stakeholders Agree: Modernize the legal framework to support move to value-driven health care

By Michelle Drozd  |    March 6, 2017
Modernizing certain laws and regulations to support the move to value-driven health care is an important step in moving our health care system forward. As part of PhRMA’s proactive policy...   Read More

How do multiple sclerosis patients define value?

By Lauren Neves  |    February 24, 2017
There are crucial conversations occurring in the health care system about how value is defined. To explore how multiple sclerosis (MS) patients, providers and payers view value, Real Endpoints...   Read More

PhRMA CEO talks White House meeting, innovation & jobs with POLITICO’s Pulse Check

By Holly Campbell  |    February 9, 2017
Following the biopharmaceutical industry’s recent meeting with President  Donald J. Trump, PhRMA president and CEO Stephen J. Ubl joined Dan Diamond on POLITICO’s Pulse Check podcast to discuss...   Read More

VIDEO: PhRMA CEO joins Fox Business anchor Neil Cavuto to discuss personal connection to value of innovation and White House meeting

By Holly Campbell  |    February 6, 2017
PhRMA president and CEO Stephen J. Ubl recently spoke with FOX Business anchor Neil Cavuto on his personal connection to the value of medical technology with his son’s type 1 diabetes diagnosis,...   Read More

VIDEO: PhRMA CEO discusses #GOBOLDLY campaign and White House meeting with CNNMoney’s Maggie Lake

By Holly Campbell  |    February 3, 2017
PhRMA president and CEO Stephen J. Ubl joined Maggie Lake on CNNMoney this week to talk about the industry’s new national campaign, GOBOLDLY™, and meeting with President Donald J. Trump. He also...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates